Because little is known about the NLRP3 inflammasome, IL-1β and IL-18 in patients with T2DM and AS, here we performed a cross-sectional study investigating these inflammatory components in patients with T2DM complicated with carotid atherosclerosis (CAS). This evidence concerns the gene IL18 and carotid atherosclerosis.